Woodline Partners LP Imago Bio Sciences, Inc. Transaction History

Woodline Partners LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$15.03 - $35.96 $1.83 Million - $4.38 Million	121,693 Added 26.62%	578,829 $20.8 Million
Q3 2022 Nov 14, 2022	SELL	$14.15 - $19.5 $3.04 Million - $4.19 Million	-214,924 Reduced 31.98%	457,136 $6.88 Million
Q2 2022 Aug 15, 2022	SELL	$11.81 - $20.92 $1.89 Million - $3.34 Million	-159,770 Reduced 19.21%	672,060 $9 Million
Q1 2022 May 16, 2022	SELL	$16.97 - $25.0 $276,594 - $407,475	-16,299 Reduced 1.92%	831,830 $16 Million
Q4 2021 Feb 14, 2022	BUY	$16.22 - $29.69 $6.94 Million - $12.7 Million	428,127 Added 101.93%	848,129 $20.1 Million
Q3 2021 Nov 15, 2021	BUY	$16.0 - $28.84 $6.72 Million - $12.1 Million	420,002 New	420,002 $8.41 Million

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.